Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
EPS (Diluted) Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
EPS (Diluted)
$0
CAGR 3-Years
49%
CAGR 5-Years
25%
CAGR 10-Years
10%
B
Bright Minds Biosciences Inc
CNSX:DRUG
EPS (Diluted)
-CA$1
CAGR 3-Years
-73%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
EPS (Diluted)
$0
CAGR 3-Years
42%
CAGR 5-Years
8%
CAGR 10-Years
8%
Repare Therapeutics Inc
NASDAQ:RPTX
EPS (Diluted)
-$2
CAGR 3-Years
-15%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
EPS (Diluted)
CA$0
CAGR 3-Years
49%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
EPS (Diluted)
CA$0
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
3%

See Also

What is Aurinia Pharmaceuticals Inc's EPS (Diluted)?
EPS (Diluted)
-0.2 USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's EPS (Diluted) amounts to -0.2 USD.

What is Aurinia Pharmaceuticals Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
10%

Over the last year, the EPS (Diluted) growth was 70%. The average annual EPS (Diluted) growth rates for Aurinia Pharmaceuticals Inc have been 49% over the past three years , 25% over the past five years , and 10% over the past ten years .

Back to Top